Insulin glargine

This publication has 9 references indexed in Scilit:

• Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.
  Diabetes, 2000
• Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
  Diabetes Care, 2000
• Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.
  Diabetes Care, 2000
• Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
  Nature Medicine, 1999
• Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens
  The Lancet, 1999
• Insulin analogues and their potential in the management of diabetes mellitus
  Diabetologia, 1999
• The Long Acting Human Insulin Analog HOE 901: Characteristics of Insulin Signalling in Comparison to Asp(B10) and Regular Insulin
  Hormone and Metabolic Research, 1998
• Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor.
  Diabetologia, 1997
• Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
  BMJ, 1978